SEARCH RESULTS FOR: "Tag: AMRN"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(9)
2018(6)
2015(3)
CATEGORIES
Analyst Update(2)
Buzz Stocks(4)
General(3)
Midday Market Check(1)
Opening View(2)
Quantitative Analysis(2)
Stocks On the Move(4)
Technical Analysis(1)
Dow Futures Under Pressure From Renewed Trade Tensions
https://www.schaeffersresearch.com/content/ezines/2019/08/09/dow-futures-under-pressure-from-renewed-trade-tensions
8/9/2019 9:24 AM
Dow Jones Industrial Average (DJI) futures are signaling a triple-digit drop this morning, as the blue-chip index looks unable to build on yesterday's strong gains. Trade tensions with China resu...
Jefferies Moves In Quickly on Amarin's Vascepa Setback
https://www.schaeffersresearch.com/content/news/2019/08/09/jefferies-moves-in-quickly-on-amarins-vascepa-setback
8/9/2019 9:19 AM
Amarin Corporation plc (NASDAQ:AMRN) is one of the biggest losers before the bell today, last seen with pre-market losses of 19.2% to trade at $14.39. A label expansion application for the company's ...
Upbeat Vascepa Expectations Boost Amarin Stock
https://www.schaeffersresearch.com/content/news/2019/07/02/upbeat-vascepa-expectations-boost-amarin-stock
7/2/2019 9:37 AM
Amarin Corporation plc (NASDAQ:AMRN) stock is trading up 6.8% at $20.55 this morning, after the cardiovascular disease specialist said it expects 2019 revenue to arrive between $380 million and $420 m...
Dow Futures Cool on New Tariff Tensions
https://www.schaeffersresearch.com/content/ezines/2019/07/02/dow-futures-cool-on-new-tariff-tensions
7/2/2019 9:21 AM
The U.S. Trade Representative's (USTR) office last night released details of a proposal to tack on $4 billion in tariffs on a number of European Union (EU) goods, which has Dow futures cooling off t...
AMRN Stock Scaling The Nasdaq After FDA Decision
https://www.schaeffersresearch.com/content/news/2019/05/29/amrn-stock-scaling-the-nasdaq-after-fda-decision
5/29/2019 9:31 AM
Shares of the pharmaceutical concern Amarin Corporation plc (NASDAQ:AMRN) are popping, after the Food and Drug Administration (FDA) granted priority review to the drugmaker's Vascepa treatment, whi...
Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.
More About
Schaeffer's
Contact
Us
Partner Center